Expertise in
20
conditions

Dr. Tena L. Rosser

Pediatric Neurology
Children's Hospital Los Angeles
4650 W Sunset Blvd, 
Los Angeles, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
20
conditions
Children's Hospital Los Angeles
4650 W Sunset Blvd, 
Los Angeles, CA 

Overview

Tena Rosser is a Pediatric Neurologist practicing medicine in Los Angeles, California.

Dr. Rosser is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis, Neurofibromatosis Type 1 (NF1), Seizures, and Aplasia Cutis Congenita.

She is actively involved in clinical research, co-authoring 34 peer reviewed articles and participating in 7 clinical trials.

Specialties

Pediatric Neurology

Licenses

Neurology with Special Qualifications in Neurology in CA

Hospital Affiliations

Children's Hosp Of Los Angeles

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MercyCare
  • EPO
  • HMO
Optima Health
  • HMO
  • POS
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Children's Hospital Los Angeles
4650 W Sunset Blvd, Los Angeles, CA 90027

Additional Areas of Focus

Dr. Rosser has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase 1/2 Trial of the MEK Inhibitor Selumetinib and Bromodomain Inhibitor ZEN-3694 With Durvalumab (MEDI4736), a PD-L1 Antibody for Sarcomas Including Malignant Peripheral Nerve Sheath Tumors
Phase 1/2 Trial of the MEK Inhibitor Selumetinib and Bromodomain Inhibitor ZEN-3694 With Durvalumab (MEDI4736), a PD-L1 Antibody for Sarcomas Including Malignant Peripheral Nerve Sheath Tumors
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Combination product
Study Drug: Selumetinib
Study Phase: Phase 2
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous Neurofibromas
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous Neurofibromas
Enrollment Status: Completed
Publish Date: February 17, 2026
Intervention Type: Drug
Study Drug: NFX-179
Study Phase: Phase 2
Phase 2 Multi Center Prospective Rand. Double Blind Placebo Cont. Parallel Design Study to Evaluate Safety & Efficacy of Topical Sirolimus for Cutaneous Angiofibromas in Subjects W/ Tuberous Sclerosis Complex Followed by Opt. Open Label
Phase 2 Multi Center Prospective Rand. Double Blind Placebo Cont. Parallel Design Study to Evaluate Safety & Efficacy of Topical Sirolimus for Cutaneous Angiofibromas in Subjects W/ Tuberous Sclerosis Complex Followed by Opt. Open Label
Enrollment Status: Terminated
Publish Date: December 01, 2025
Intervention Type: Drug
Study Drug: Sirolimus
Study Phase: Phase 2
A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
Enrollment Status: Completed
Publish Date: May 02, 2025
Intervention Type: Drug
Study Drug: Binimetinib
Study Phase: Phase 2
A Phase II Trial of Poly-ICLC for Progressive, Previously Treated Low-Grade Gliomas in Children and Young Adults With Neurofibromatosis Type 1
A Phase II Trial of Poly-ICLC for Progressive, Previously Treated Low-Grade Gliomas in Children and Young Adults With Neurofibromatosis Type 1
Enrollment Status: Terminated
Publish Date: March 21, 2025
Intervention Type: Drug
Study Drug: Poly ICLC
Study Phase: Phase 2
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Drug: Cabozantinib
Study Phase: Phase 2
A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
Enrollment Status: Terminated
Publish Date: October 27, 2021
Intervention Type: Procedure, Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

34 Total Publications

Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments.
Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments.
Journal: Journal of neuro-oncology
Published: February 09, 2025
Similar Doctors
Expertise in
7
conditions
Dr. Shafali S. Jeste
Pediatric Neurology
Expertise in
7
conditions
Dr. Shafali S. Jeste
Pediatric Neurology
Referral may be required

Office

300 Medical Plz, 
Los Angeles, CA 
 (9.2 miles away)
310-825-9989
Languages Spoken:
English
See accepted insurances

Shafali Jeste is a Pediatric Neurologist practicing medicine in Los Angeles, California. Dr. Jeste is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Autism Spectrum Disorder, Tuberous Sclerosis Complex, Tuberous Sclerosis, and Cortical Dysplasia.

Expertise in
13
conditions
Dr. John R. Crawford
Pediatric Neurology
Expertise in
13
conditions
Dr. John R. Crawford
Pediatric Neurology
Referral may be required
Before you request
505 South Main Street, Suite 350, 
Orange, CA 
 (32.7 miles away)
714-509-7982
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Crawford is a Pediatric Neurologist practicing medicine in Orange, California. Dr. Crawford is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Gliomatosis Cerebri, Embryonal Tumor with Multilayered Rosettes, Seizures, and Neurofibromatosis. Dr. Crawford is currently accepting new patients.

Expertise in
11
conditions
Dr. Deborah L. Holder
Pediatric Neurology
Expertise in
11
conditions
Dr. Deborah L. Holder
Pediatric Neurology
Referral may be required

Steven Spielberg Pediatric Research Center

8723 Alden Dr Ste 240, 
Los Angeles, CA 
 (5.0 miles away)
310-423-7779
Languages Spoken:
English
See accepted insurances

Deborah Holder is a Pediatric Neurologist practicing medicine in Los Angeles, California. Dr. Holder is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Myoclonic Epilepsy, Seizures, Epilepsy, and Epilepsy with Myoclonic-Atonic Seizures.

Frequently Asked Questions about Dr. Tena L. Rosser

How do I make an appointment with Dr. Tena L. Rosser?

You can book an appointment with Dr. Tena L. Rosser by calling their office at 323-361-2471. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Tena L. Rosser a top-rated expert for Neurofibromatosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tena L. Rosser is classified as an Elite expert for Neurofibromatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Tena L. Rosser specialize in?

While Dr. Tena L. Rosser is a Pediatric Neurology, they have specific expertise in Neurofibromatosis, Neurofibromatosis Type 1 (NF1), and Seizures. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Neurology.

Does Dr. Tena L. Rosser participate in research or clinical trials?

Yes. Dr. Tena L. Rosser has published 34 articles and abstracts on conditions like Neurofibromatosis. You can view a list of Dr. Tena L. Rosser's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Tena L. Rosser accept my insurance?

Dr. Tena L. Rosser accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 323-361-2471 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosser's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 46 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile